- Report
- August 2025
- 154 Pages
Global
From €2406EUR$2,650USD£2,063GBP
- Report
- May 2026
- 150 Pages
Global
From €5402EUR$5,950USD£4,631GBP
- Report
- May 2026
- 150 Pages
Global
From €5402EUR$5,950USD£4,631GBP
- Report
- January 2026
- 188 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- July 2026
- 194 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- July 2026
- 192 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- June 2026
- 189 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- June 2026
- 197 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- June 2026
- 186 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- June 2026
- 190 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- June 2026
- 180 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- June 2026
- 183 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- January 2026
- 191 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- January 2026
- 190 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- January 2026
- 191 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- January 2026
- 194 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- January 2026
- 184 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- January 2026
- 196 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- January 2026
- 185 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP
- Report
- August 2025
- 193 Pages
Global
From €3219EUR$3,545USD£2,759GBP
€3577EUR$3,939USD£3,066GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more